Logo image of FBLA

FB BANCORP INC (FBLA) Stock Fundamental Analysis

NASDAQ:FBLA - Nasdaq - US31425A1097 - Common Stock - Currency: USD

11.37  -0.03 (-0.26%)

Fundamental Rating

0

FBLA gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 402 industry peers in the Banks industry. Both the profitability and financial health of FBLA have multiple concerns. FBLA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FBLA was profitable.
FBLA Yearly Net Income VS EBIT VS OCF VS FCFFBLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.02%, FBLA is doing worse than 90.55% of the companies in the same industry.
FBLA's Return On Equity of 0.16% is on the low side compared to the rest of the industry. FBLA is outperformed by 90.55% of its industry peers.
Industry RankSector Rank
ROA 0.02%
ROE 0.16%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FBLA Yearly ROA, ROE, ROICFBLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0.2 0.4 0.6 0.8 1

1.3 Margins

Looking at the Profit Margin, with a value of 0.22%, FBLA is doing worse than 90.55% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for FBLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 0.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBLA Yearly Profit, Operating, Gross MarginsFBLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 1 2 3

More info and screens

0

2. Health

2.1 Basic Checks

FBLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
FBLA has about the same amout of shares outstanding than it did 1 year ago.
FBLA has a worse debt/assets ratio than last year.
FBLA Yearly Shares OutstandingFBLA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
FBLA Yearly Total Debt VS Total AssetsFBLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

A Debt/Equity ratio of 0.79 indicates that FBLA is somewhat dependend on debt financing.
FBLA's Debt to Equity ratio of 0.79 is on the low side compared to the rest of the industry. FBLA is outperformed by 82.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.14%
FBLA Yearly LT Debt VS Equity VS FCFFBLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
FBLA Yearly Current Assets VS Current LiabilitesFBLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for FBLA have decreased strongly by -46.99% in the last year.
The Revenue has been growing slightly by 7.78% in the past year.
EPS 1Y (TTM)-46.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)7.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBLA Yearly Revenue VS EstimatesFBLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 20M 40M 60M
FBLA Yearly EPS VS EstimatesFBLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1137.00 indicates a quite expensive valuation of FBLA.
Based on the Price/Earnings ratio, FBLA is valued expensively inside the industry as 88.81% of the companies are valued cheaper.
FBLA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 1137
Fwd PE N/A
FBLA Price Earnings VS Forward Price EarningsFBLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBLA Per share dataFBLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FBLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FB BANCORP INC

NASDAQ:FBLA (3/7/2025, 8:23:29 PM)

11.37

-0.03 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.26%
Inst Owner ChangeN/A
Ins Owners1.61%
Ins Owner Change0.15%
Market Cap225.58M
AnalystsN/A
Price TargetN/A
Short Float %1.57%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1137
Fwd PE N/A
P/S 1.88
P/FCF N/A
P/OCF N/A
P/B 1.4
P/tB 1.46
EV/EBITDA N/A
EPS(TTM)0.01
EY0.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.03
BVpS8.14
TBVpS7.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.22%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC8.14%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-131.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.82%
OCF growth 3YN/A
OCF growth 5YN/A